Correlation of Salivary Gland FNA Reporting Using the Modified Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) and Intraoperative Frozen Section Evaluation with Final Histopathology Report for Major Salivary Gland Neoplasms. [PDF]
Thiagarajan S, Sathe P, Bal M, Patil A.
europepmc +1 more source
Abstract Transmembrane mucin 1 (tMUC1) provides oral mucosal barrier against pathogens. The invasion of oncopathogenic microbes can promote cancerous proliferation of cells via inflammatory responses, abnormal cellular signaling, angiogenesis, anti‐adhesion, and tumorigenesis.
Lauriina Soiniemi +4 more
wiley +1 more source
Cannabis Use and Benign Salivary Gland Neoplasms.
Gallagher TJ +4 more
europepmc +1 more source
Host genetic variation in immune regulation and cell signalling genes was associated with microbiome composition across vaginal, gut, oral and skin sites, while associations involving metabolic function, epithelial barrier integrity and hormonal processes were more site‐specific. Overall, our findings indicate that host genetic variation contributes to
Isabella Margaret Davidson +4 more
wiley +1 more source
Clear cell changes in salivary gland neoplasms: A 20-year retrospective study. [PDF]
Woods T +4 more
europepmc +1 more source
Prevalence of Oral Mucosal Lesions in Finnish Adults—Findings From the Healthy Finland Survey
ABSTRACT Objectives Oral mucosal lesions (OMLs) are abnormal findings of the oral mucosa. OMLs can be a localized disease due to trauma or infections, a manifestation of systemic or dermatological disease, or a sign of neoplasia. The aim of this study was to assess the prevalence of OMLs among Finnish adults.
Mirjami J. Rintala +5 more
wiley +1 more source
Expanding primary cells from mucoepidermoid and other salivary gland neoplasms for genetic and chemosensitivity testing. [PDF]
Alamri AM +10 more
europepmc +1 more source
Bringing Gene Therapy Into Real World Clinical Practice
ABSTRACT Introduction Adeno‐associated virus (AAV)‐based gene therapy for haemophilia has shifted therapeutic paradigms by enabling hepatic gene transfer, restoring endogenous clotting factor expression, and reducing reliance on conventional prophylactic treatments. Two products, valoctocogene roxaparvovec (haemophilia A) and etranacogene dezaparvovec (
Wolfgang Miesbach +2 more
wiley +1 more source
Targeting HER2/neu Oncogene Overexpression With Ado-Trastuzumab Emtansine in the Treatment of Metastatic Salivary Gland Neoplasms: A Single-Institution Experience. [PDF]
Swed BL, Cohen RB, Aggarwal C.
europepmc +1 more source
Italian Patients Journey for Gene Therapy in Haemophilia A
ABSTRACT Introduction Gene therapy (GT) provides sustained FVIII levels without repeated infusions in Hemophilia A (HA) patients thus overcoming a major limitation of replacement therapy. However, issues remain e.g., patient selection criteria, duration and variability of transgene expression, quality of life and long‐term safety.
Giovanni Di Minno +19 more
wiley +1 more source

